| Issue Date | Title | Type | Author(s) |
| 2020 | Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study | Articulo | Dimopoulos, M.A. (Meletios A.) ; Lonial, S. (Sagar); White, D.J. (Darrell J.); Moreau, P. (Philippe); Weisel, K. (Katja); San-Miguel, J.F. (Jesús F.); Shpilberg, O. (Ofer); Spicka, I. (Ivan); Walter-Croneck, A. (Adam); Magen, H. (Hila); Mateos, M.V. (María Victoria); Belch, A. (Andrew); Reece, D. (Donna); Beksac, M. (Meral); Spencer, A. (Andrew); Oakervee, H. (Heather); Orlowski, R.Z. (Robert Z.); Shpilberg, O. (Ofer); Taniwaki, M. (Masafumi); Röllig, C. (Christoph); Einsele, H. (Hermann); Matsumoto, M. (Morio); Wu, K.L. (Ka Lung); Anderson, K. (Kenneth C.); You, Y.M. (Ying-Ming); Ganetsky, A. (Alex); Singhal, A.K. (Anil K.); Richardson, P.G. (Paul G.) |
| 2018 | Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting | Articulo | Richardson, P.G. (Paul G.); San-Miguel, J.F. (Jesús F.); Moreau, P. (Philippe); Hajek, R. (R.); Dimopoulos, M.A. (Meletios A.); Laubach, J.P. (Jacob P.); Palumbo, A. (Antonio); Luptakova, K. (Katarina); Cessario, R. (Romanus); Romanus, D. (Dorothy); Skacel, T. (Tomas); Kumar, S. (Shaji); Anderson, K. (Kenneth C.) |
| 2020 | Melflufen for relapsed and refractory multiple myeloma | Articulo | Oriol, A. (Albert); Larocca, A. (Alessandra); Leleu, X. (Xavier); Hajek, R. (R.); Hassoun, H. (Hani); Rodriguez-Otero, P. (Paula); Paner, A. (Agne); Schjesvold, F.H. (Fredrik H.); Gullbo, J. (Joachim); Richardson, P.G. (Paul G.) |
| 2023 | Overall survival with daratumumab, lenalidomide, and dexamethasone in previously treated multiple myeloma (POLLUX): a randomized, open-label, phase III trial | Articulo | Dimopoulos, M.A. (Meletios A.); Oriol, A. (Albert); Nahi, H. (Hareth); San-Miguel-Izquierdo, J. (Jesús Fernando); Bahlis, N.J. (Nizar J.); Usmani, S.Z. (Saad Z.); Rabin, N. (Neil); Orlowski, R.Z. (Robert Z.); Suzuki, K. (Kenshi); Plesner, T. (Torben); Yoon, S.S. (Sung-Soo); Ben-Yehuda, D. (Dina); Richardson, P.G. (Paul G.); Goldschmidt, H. (Hartmut); Reece, D. (Donna); Ahmadi, T. (Tahamtan); Qin, X. (Xiang); Garvin-Mayo, W. (Wendy); Gai, X. (Xue); Carey, J. (Jodi); Carson, R. (Robin); Moreau, P. (Philippe) |
| 2010 | Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma | Articulo | Mateos, M.V. (María Victoria); Cibeira, M. (M.T.); Richardson, P.G. (Paul G.); Prosper-Cardoso, F. (Felipe); Oriol, A. (Albert); Rubia, J. (Javier) de la; Lahuerta, J.J. (Juan José); García-Sanz, R. (Ramón); Extremera, S. (S.); Szyldergemajn, S. (Sergio); Corrado, C. (C.); Singer, H. (H.); Mitsiades, C.S. (Constantine S.); Anderson, K.C. (K.C.); Bladé, J. (Joan); San-Miguel, J.F. (Jesús F.) |
